Search by disease area - Any -Blood cancerBreast CancerColorectal cancerLung cancerMelanomaSARS-CoV-2 Search by conference - Any -AMPECP The Importance of Fast Biomarker Testing in Breast Cancer Biocartis Webinar 2024 Dr. Claus Hann von Weyhern - Prof Daniele Generali, MD DPhil - Prof Dr. Sigurd F. Lax Watch now Rapid qPCR based IDH1/IDH2 mutation screening in solid tumors and hematologic malignancies without extraction AMP 2023 Dr. Tejus A. Bale, MD-PhD, Neuropathologist and Diagnostic Molecular Pathologist, MSKCC Watch now Q&A Biocartis Symposium ECP 2022 Basel ECP Congress 2022 Prof. Dr. Jesus Garcia-Foncillas MD PhD, Dr. Alison Finall, Prof. Dr. Arndt Hartmann med Watch now Multicenter NSCLC comparison study using Idylla GeneFusion ECP Congress 2022 Prof. Dr. Arndt Hartmann med. Watch now Idylla MSI Assay as a new tool for the detection of microsatellite instability ECP Congress 2021 Dr. Anaïs Pujals Watch now Feasibility of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy NSCLC samples ECP Congress 2021 Dr. Umberto Malapelle Watch now Multicenter study using the Idylla GeneFusion prototype cartridge ECP Congress 2021 Dr. Audrey Lupo Watch now The Value of Idylla in Times of COVID-19 Pandemic Biocartis Webinar 2021 Dr. Umberto Malapelle Watch now Idylla MSI Testing in Colorectal and Endometrial Cancer ECP Congress 2019 Xavier Matias-Guiu Guia, M.D. Watch now Idylla GeneFusion: Revolutionary Precision Testing for Gene Rearrangements ECP Congress 2022 Bieke Van Dorst, PhD, Senior Scientist Watch now A New Era in MSI Testing ECP Congress 2018 Bram De Craene, PhD Watch now The Idylla MSI: A Laboratory User Perspective ECP Congress 2018 Sofie Metsu, PhD Watch now
